Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01405183 · ClinicalTrials.gov registry record
Association Between Hepatitis C Infection and Renal Cell Carcinoma
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 240
- Enrollment target
NCT01405183 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 240 participants.
The verdict
NCT01405183 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).
Interventions
- OTHER Hepatitis C testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01405183
The ClinicalTrials.gov registry entry for NCT01405183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hepatitis C testing is the first listed.
NCT01405183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01405183 about?
NCT01405183 is a clinical study titled "Association Between Hepatitis C Infection and Renal Cell Carcinoma". The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer pa...
What is the current status of trial NCT01405183?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2011-01. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01405183?
The interventions under investigation include: Hepatitis C testing (OTHER).
Who is sponsoring clinical trial NCT01405183?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.